FDA Approves IBUPROFEN AND FAMOTIDINE — Ascend Laboratories, LLC

Ascend Laboratories has received FDA approval for the generic combination drug ibuprofen and famotidine, placing it in direct competition with branded products and anticipating their share of the OTC prescription-drug clash market. The launch of this new formulation is expected to capitalize on the growing demand for cost-effective ulcer prophylaxis alongside pain relief.